Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_747_Библиотеки_им_академика_М_И_Перельмана
.pdf
This page intentionally left blank
https://t.me/med1917

30
https://t.me/med1917
Extrapleural pneumonectomy
JOHN C. KUCHARCZUK, MD
Assistant Professor of Surgery, Division of Cardiothoracic Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
LARRY R. KAISER, MD
The John Rhea Barton Professor and Chairman, Department of Surgery, University of Pennsylvania; Surgeon-in-Chief, University of
Pennsylvania Health System, Philadelphia, PA, USA
HISTORY
The extrapleural pneumonectomy operation was described in
1949 for application in patients with pleural-pulmonary
tuberculosis. Today, the procedure is used almost exclusively
in carefully selected patients with malignant pleural mesothelioma. The intent of the procedure, although elusive, is cure
and as such the procedure is performed as part of a multimodality treatment regimen. Adequate palliation of symptoms can often be obtained in patients who are not candidates
for cure by less invasive/aggressive procedures with lower
morbidity and mortality rates.
PRINCIPLES AND JUSTIFICATION
The relationship between malignant pleural mesothelioma
and asbestos exposure was observed over 45 years ago in
South African miners. Unfortunately, asbestos use was widespread in construction and heavy industry worldwide, exposing large numbers of workers. In the 1970s, American
government agencies including the Occupational Safety and
Health Administration and the Environmental Protection
Agency set forth strict regulations for asbestos exposures in
the workplace and nonoccupational setting. Because of these
regulations, the incidence of malignant pleural mesothelioma, which presents 30–40 years after exposure, has peaked
in the United States. Worldwide, however, the incidence of
malignant pleural mesothelioma is expected to increase for
the next 20–30 years.
Traditionally, malignant pleural mesothelioma has been
viewed as a locally aggressive disease; it was thought that
metastatic disease occurred late. Largely because of this point
of view, the radical operations proposed for the eradication of
advanced pleural pulmonary tuberculosis were modified and
applied to patients with malignant pleural mesothelioma.
Initial results from series published in the 1970s and 1980s
revealed only a few long-term survivors with relatively high
morbidity and mortality rates. Recently, with improved
patient selection and refined surgical techniques, 2-year survival rates have been reported in the 30% range with acceptable morbidity and mortality. Combined multimodality
treatments hold out the prospect of even better future outcomes.
PREOPERATIVE EVALUATION AND PATIENT
SELECTION
The clinical difficulty in managing patients with malignant
pleural mesothelioma begins with diagnosis. Patients usually
present with shortness of breath, chest pain, and imaging
studies showing a pleural effusion and pleural nodularity.
Many will have had thoracentesis and/or closed pleural
biopsy which may still be cytologically inconclusive. Needle
aspiration of a pleural lesion usually provides inadequate
material for a definitive diagnosis. Usually, a video-assisted
biopsy with specialized immunohistochemical staining and
electron microscopy is required to finalize the diagnosis.
Securing an accurate diagnosis is critical. Patients with pleural carcinomatosis will not benefit from extrapleural pneumonectomy; they would be better served by other palliative
or experimental treatments. We use a single pulmonary
pathologist with special interest and expertise to review and
confirm all malignant mesothelioma cases. In institutions
without such expertise, outside pathological consultation
should be obtained.
In symptomatic patients with large pleural effusions talc
pleurodesis is performed at the time of diagnostic thoracoscopy if the lung fully expands. Despite popular notion,

316 Extrapleural pneumonectomy
https://t.me/med1917
effective pleurodesis does not complicate later extrapleural
pneumonectomy; it actually makes establishment of the
extrapleural plane easier and provides symptomatic relief
while evaluation is underway.
An interesting and early observation in malignant pleural
mesothelioma was that patients with epithelioid histology
had the best outcomes following aggressive surgery. By contrast, patients with mixed or sarcomatoid features had poor
outcomes regardless of the treatment selected. In our current
practice we consider only patients with pure epithelioid histology for extrapleural pneumonectomy. Patients with mixed
or sarcomatoid pathology are encouraged to consider
enrolling in experimental treatment trials. This histological
selection criterion is particularly important if patients are to
be subjected to the potential morbidity and mortality of
extrapleural pneumonectomy. The procedure should be confined to those patients with the best chance of long-term survival where the potential benefit justifies the risk.
Once the diagnosis of pure epithelioid mesothelioma is
confirmed, the preoperative evaluation focuses on determining the patients’ extent of disease and fitness to undergo
aggressive surgical resection. Unfortunately, no staging system or preoperative evaluation is universally agreed upon for
patients with malignant pleural mesothelioma. Presently, the
staging systems used include: the Union International Contre
le Cancer Staging System, The New International Staging
System proposed by the International Mesothelioma Interest
Group, The Brigham and Women’s Hospital/Dana Farber
Cancer Institute Staging System, and the original Butchart
Staging System proposed in the late 1970s. Regardless of the
staging system used, patients considered for extrapleural
pneumonectomy must have disease confined to a single
hemithorax. As previously mentioned, the traditional view of
malignant pleural mesothelioma as strictly a local disease is
erroneous. We have come to understand that a substantial
number of patients have metastatic disease to the mediastinal
lymph nodes and/or through the diaphragm into the peritoneal cavity, or into the other pleural space. Our current pre-
operative assessment includes cervical mediastinoscopy and
diagnostic laparoscopy with biopsy. Often, we perform these
procedures separately to allow for complete assessment of the
pathological specimens. Patients determined to have mediastinal nodal metastasis and/or peritoneal involvement are
not offered extrapleural pneumonectomy.
Physiological evaluation also requires experience and
mature surgical judgment. The performance of an
extrapleural pneumonectomy puts a significant physiological
stress on the patient above and beyond that imposed by a
standard pneumonectomy. The intrapericardial procedure
and the excision of the hemidiaphragm add to the morbidity
of the procedure. All patients undergo preoperative cardiac
evaluation and pulmonary function testing. Eligible patients
should have a postoperative predicted FEV1of greater than 1
liter. Although we do not have strict age criteria, we offer the
procedure only rarely in those over age 60. Perhaps this
approach is being somewhat conservative, but older patients
tend to show their age following this procedure, and the mortality in those over age 60 is considerable.
OPERATION
Right extrapleural pneumonectomy
The patient is brought to the operating room, and a thoracic
epidural catheter is placed for intra- and postoperative pain
management. Preoperative antibiotics are administered, and
pneumatic compression boots are applied to avoid venous
stasis in the lower extremities. General anesthesia is induced,
and the patient is intubated with a left-sided double-lumen
endotracheal tube. A flexible pediatric bronchoscope is used
to examine the airway and position the tube for isolated lung
ventilation. The tube is secured. A nasogastric tube is placed
and used later as a guide when the extrapleural dissection
approaches the esophagus. The patient is repositioned in the
left lateral decubitus manner.

A long skin incision is made along the sixth rib.
https://t.me/med1917
1
Electrocautery is used to achieve hemostasis in the subcutaneous tissues. The latissimus dorsi muscle is divided
with electrocautery. When possible, we like to mobilize and
spare the serratus anterior muscle as this can be used as a
pedicled muscle flap later in the procedure if needed.
The sixth rib is identified, and its periosteum is scored. A
periosteal elevator is used to completely strip the periosteum
from the rib, and then the entire rib is removed with a bone
cutter. Removing the sixth rib facilitates the initiation of the
extrapleural dissection. We like to begin the dissection
sharply by establishing the extrapleural plane under the fifth
rib. Once the plane is established the entire lateral dissection
is done quickly and bluntly with a dissecting hand. Chest wall
bleeding is temporarily controlled with packing sponges.
After the lateral extrapleural dissection is done both superiorly and inferiorly, a chest retractor can be placed. The packing sponges are removed, and any ongoing chest wall
bleeding is controlled with electrocautery or the argon beam
coagulator.
Operation 317
2
1
Dissection proceeds around the apex of the lung in a
2
more controlled manner with sharp scissor dissection.
Care must be taken to avoid injury to the subclavian artery
and vein. As the dissection moves medially, the internal
mammary vessels are identified and allowed to remain on the
chest wall. Likewise the pleural envelope is carefully dissected
away from the superior vena cava and azygous vein.

318 Extrapleural pneumonectomy
https://t.me/med1917
Attention is directed posteriorly for dissection of the
3
specimen from the esophagus. The nasogastric tube is
palpated in the esophagus and used as a guide. The attachments between the extrapleural plane and the esophagus are
divided sharply as far inferiorly as possible. Up to this point,
no irreversible moves have been made. If the disease is found
to be more extensive than anticipated and to involve nonresectable thoracic structures or to have invaded through the
chest wall, the procedure can be aborted. If the mass is still
deemed resectable, we move onto the diaphragmatic portion
of the procedure.
3
Several different techniques have been described for
4
facilitating the diaphragmatic dissection, resection, and
reconstruction. We have found the most effective technique
to be simply making a second intercostal muscle incision two
interspaces lower without making any additional skin incisions. A small child chest retractor is used and exposure to the
diaphragm is excellent. The diaphragmatic division is begun
at the lateral attachment of the diaphragm to the chest wall.
4
A small incision is made, and the underlying peritoneum
5
is swept away with a sponge stick.
5

Once the peritoneum is pushed away with a sponge
https://t.me/med1917
6
stick, the lateral diaphragmatic resection is completed
with electrocautery.
Moving medially, we switch to sharp dissection with tissue
scissors. The pleural envelope is carefully dissected away from
the inferior vena cava and distal esophagus. At this juncture
we mass ligate all tissue on the spine between the esophagus
and the aorta with a 2-0 silk suture as a prophylactic maneuver to decrease the incidence of thoracic duct leak. Dissection
continues in a cephalad direction toward the pericardium.
The chest retractor is removed and repositioned into the sixth
intercostal space incision. The pericardium is opened and
removed with the specimen.
Operation 319
6
The right main pulmonary artery is isolated within the
7
pericardium and taken with a single firing of an Endo
GIA vascular stapling device. Likewise the pulmonary veins
are isolated within the pericardium and divided with a vascular stapling device. Finally, the bronchus is circumferentially
dissected, small bronchial vessels are controlled with electrocautery, and the right mainstem bronchus is taken flush with
the carina using a TA stapling device. The specimen is
removed from the field, oriented, and forwarded to pathology
for evaluation.
Meticulous hemostasis is required. Residual chest wall
bleeding from the endothoracic fascia is controlled with electrocautery or the argon beam coagulator. When available, the
pericardial fat pad is mobilized to cover the bronchial stump.
Otherwise, the uncut serratus anterior muscle is mobilized
and transposed into the chest to provide a buttress for the
bronchial stump. When it is required, the serratus anterior
muscle is brought into the chest through the third intercostal
space. We reoutinely buttress a right pneumonectomy stump.
7

320 Extrapleural pneumonectomy
https://t.me/med1917
Next, attention is turned towards diaphragmatic and
8
pericardial reconstruction. The retractor is moved to the
lower intercostal incision. The diaphragm is reconstructed
with a 2-mm polytetrafluoroethylene (PTFE) soft tissue
patch. The patch is secured to the chest wall laterally by placement of interrupted #1 Prolene sutures. The sutures are
placed at close intervals around the ribs to provide secure
purchase. Medially, an unsecured open area remains for passage of the esophagus and inferior vena cava. On the right
side the pericardium must be reconstructed in order to prevent herniation of the heart with compromise of venous
return, a potentially lethal situation.
8
9a
9b
The pericardium is reconstructed with a 0.1-mm PTFE
9
pericardial patch. The patch is fenestrated to allow
drainage and avoid tamponade. It is secured to the cut edges
of the pericardium with 4-0 Prolene suture placed in a running fashion. Inferiorly, the patch is secured to the diaphragmatic patch with several interrupted Prolene sutures.

10
https://t.me/med1917
Operation 321
The completed repair is shown. The entire chest is
irrigated with several liters of sterile saline.
A 28 Fr. chest tube is brought through a separate stab incision and directed toward the apex. The chest tube is connected to a balanced drainage system with a safety
mechanism that precludes any attachment to suction.
Number 1 braided absorbable sutures are placed in a pericostal position. The ribs are brought together with the aid of
a Bailey rib approximator. The pericostal sutures are secured.
The incision is irrigated, and the latissimus dorsi muscle is
reapproximated with a running number absorbable suture.
The subcutaneous tissues are approximated with running
absorbable suture, and the skin is closed with a subcuticular
suture. The patient is returned to the supine position and
allowed to emerge from anesthesia.
Left extrapleural pneumonectomy
Performance of the left extrapleural pneumonectomy is technically easier than the right. Following induction of general
anesthesia, a right-sided double-lumen endotracheal tube is
placed. The tube is positioned for isolated lung ventilation
with a pediatric bronchoscope. The Murphy’s eye of the
right-sided double-lumen endobronchial tube is aligned with
the right upper lobe orifice. Improper placement can result in
right upper lobe consolidation with hypoxia during single
lung ventilation. The tube also can migrate during patient
positioning or extrapleural dissection. The pediatric bronchoscope remains with the anesthesia team during the procedure, and confirmation of tube position should be performed
if the patient becomes hypoxic during single lung ventilation.
10
The patient is repositioned in the right lateral decubitus
position. A long posterolateral incision is made along the left
sixth rib. The latissimus dorsi muscle is divided with electrocautery. The serratus anterior muscle is mobilized and spared
when possible. The periosteum of the sixth rib is stripped,
and the entire sixth rib is removed. The dissection is begun by
sharply establishing an extrapleural plane under the fifth rib,
as was described above for the right-sided pneumonectomy.
Once the plane is developed, the entire lateral dissection is
performed with a dissecting hand. The space is packed with
surgical sponges to control chest wall bleeding, and the chest
retractor is placed. The sponges are removed, and chest wall
hemostasis is obtained with electrocautery or the argon beam
coagulator. As on the right side, careful sharp dissection is
used at the apex to avoid injury to the subclavain artery and
vein. Likewise medially, the internal mammary vessels are left
on the chest wall. As dissection continues along the mediastinum, care is taken to avoid injury to the left vagus and left
recurrent laryngeal nerve. Damage to the recurrent laryngeal
nerve will lead to postoperative left vocal cord paralysis with
susceptibility to aspiration. This complication can be life
threatening following pneumonectomy.
Attention now is directed posteriorly. The extrapleural dissection is continued along the aorta with careful scissor dissection. As with right extrapleural pneumonectomy, we make
an accessory intercostal incision through the eighth intercostal space and move the rib spreader to this interspace. This
maneuver provides excellent exposure to the diaphragm. The
extrapleural dissection is continued bluntly well into the
costophrenic sulcus. The diaphragmatic dissection is started

322 Extrapleural pneumonectomy
https://t.me/med1917
by incision of the lateral attachments of the diaphragm to the
chest wall. The peritoneal membrane is swept away, and the
diaphragmatic resection is continued with electrocautery.
Occasionally, the peritoneal cavity is entered inadvertently.
This situation is not a particular problem since the
diaphragm is to be reconstructed. Care is taken medially
along the diaphragmatic hiatus to avoid injury to the esophagus and left vagus nerve. Once the inferior dissection is complete, the retractor is moved back to the fifth intercostal
space. The pericardium is opened and widely incised to complete the dissection. The left main pulmonary artery is isolated in an intrapericardial location and ligated and divided
with an endoscopic linear stapling device. As the intrapericardial portion of the left pulmonary artery is short, care must be
taken to avoid injury or encroachment on the main or right
pulmonary artery. The upper and lower pulmonary veins are
encircled within the pericardium and individually divided
with a vascular stapling device. Finally, the left main
bronchus is circumferentially dissected back to the carina and
taken with a stapling device. The bronchus is divided flush
with the carina to avoid an excessively long stump which is
susceptible to breakdown. The left-sided stump retracts back
into the mediastinum and usually does not require buttressing as is required on the right. Hemostasis is confirmed, and
attention is directed toward diaphragmatic reconstruction.
The retractors are moved to the lower intercostal incision.
The diaphragm is reconstructed with a 2-mm thick PTFE soft
tissue patch. The patch is secured to the chest wall laterally by
placement of interrupted #1 sutures in the same fashion as
used on the right. Unlike on the right side, pericardial reconstruction is not required on the left since torsion with compromise of venous return is not an issue in the left chest.
The entire chest is irrigated with several liters of sterile
saline. A 28Fr. chest tube is brought through a separate stab
incision and directed toward the apex. The chest tube is connected to a balanced pneumonectomy drainage device. #1
absorbable sutures are placed in a pericostal position. The rest
of the closure proceeds as usual as described above.
The patient is returned to the supine position and allowed
to emerge from anesthesia.
POSTOPERATIVE CARE
Our intent is to extubate all patients in the operating room
following extrapleural pneumonectomy. After a short stay in
the postanesthesia recovery area, they are transferred to the
thoracic surgical unit for their postoperative care. The pneumonectomy tube is removed the following morning after a
chest X-ray confirms the midline position of the mediastinum. The epidural catheter remains connected to a
patient-controlled epidural administration device for 5 days.
During this time, patients receive intensive pulmonary physiotherapy. Starting on postoperative day 2, they are ambulated three times per day in the hall with assistance. A chest
radiograph is obtained every other day to follow appropriate
filling of the pneumonectomy space. Rapid filling may indicate unrecognized bleeding and the need for re-exploration.
The hemoglobin is checked every other day as patients have a
tendency to become progressively anemic as the pneumonectomy space fills. Symptomatic patients with a hemoglobin
level below 8 mg/dL are transfused. Occasionally, the space
fills rapidly with a shift of the mediastinum. This situation
requires drainage of the space to prevent hemodynamic
embarrassment. Patients with an uncomplicated course are
usually discharged on postoperative day 7.
Pitfalls, complications
The most common intraoperative complication is bleeding.
Chest wall bleeding should be controlled as the operation
progresses to avoid excessive blood loss. This goal is facilitated by use of the argon beam coagulator. Catastrophic
bleeding can occur due to injury of major vascular structures
during dissection around the apex of the chest or when dissecting around the inferior vena cava. The complication is
avoided by careful attention to detail and absolute familiarity
with the anatomy.
Transient hypotension in the immediate postoperative
period is often related to sympathectomy with vasodilation
due to the thoracic epidural administration of narcotic or
local anesthesia. The blood pressure is supported with intravenous vasoactive drugs such as neosynephrine. Large fluid
boluses are avoided. Profound hypotension with tamponade
physiology may be due to acute mediastinal shift. Because of
our use of a balanced pneumonectomy drainage system, we
have avoided this complication. It must, however, be considered in those units which use only a single catheter with a
stopcock to add or remove air to move the mediastinum to a
midline position. An overly tight pericardial patch can cause
constriction, with tamponade physiology. Finally, if the fenestrations in the pericardial patch are too small to allow free
drainage, even a small amount of clot within the reconstructed pericardium can result in tamponade. Early recognition of these potential problems is mandatory if the patient is
to be salvaged.
From a pulmonary perspective, the most dangerous complication is development of postpneumonectomy pulmonary
edema. Unfortunately, the etiological factors causing this
phenomenon remain obscure. When it occurs, the treatment
is supportive. In any event, we limit perioperative fluid
administration in an attempt to minimize this complication.
The complication occurs much more commonly following
right extrapleural pneumonectomy than left. This complication usually manifests within the first 96 hours following the
resection.
Postoperative space infections are particularly difficult to
manage because of the presence of prosthetic material used to
reconstruct the diaphragm and the pericardium. In patients
without pneumonectomy stump breakdown, early space
infection occasionally can be managed with complete

Further reading 323
https://t.me/med1917
drainage, high volume lavage, and antibiotics. Those patients
presenting with a pneumonectomy stump breakdown require
open window thoracostomy and removal of prosthetic material. If this problem occurs on the right side before the mediastinum is fixed, the prosthetic material must be removed in
a staged fashion.
OUTCOME
The outcomes following extrapleural pneumonectomy alone
are disappointing. Surgery as a single treatment modality
usually does not provide long-term survival. Currently, the
best outcomes are in highly selected patients with epithelioid
mesothelioma, negative lymph nodes, and negative resection
margins receiving trimodality therapy including chemotherapy and radiation therapy. In this small cohort 5-year survival
is in the 35–40% range. Clearly, the ideal treatment regimen
for malignant pleural mesothelioma has yet to be defined.
FURTHER READING
Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumectomy
in the management of diffuse malignant mesothelioma of the
pleura. Experience with 29 patients. Thorax 1976; 31: 15–24.
Robinson BW, Lake RA. Advances in malignant mesothelioma. New
England Journal of Medicine 2005; 353: 1591–603.
Sugarbaker DJ, Garcia JP. Multimodality therapy for malignant pleural
mesothelioma. Chest 1997; 112: 272S–5S.
Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins,
extrapleural nodal status, and cell type determine postoperative
long-term survival in trimodality therapy of malignant pleural
mesothelioma: results in 183 patients.
Cardiovascular Surgery 1999; 117: 54–65.
Sugarbaker DJ. Jalkitsch MT, Bueno R et al. Prevention, early detection
and management of complication after 328 consecutive extrapleural
pneumonectomies. Journal of Thoracic and Cardiovascular Surgery
2004; 128: 138–46.
Journal of Thoracic and
Соседние файлы в папке Библиотека им академика М.И. Перельмана
